Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Veeva Systems Acquires AdvantageMS

Published: Wednesday, June 26, 2013
Last Updated: Wednesday, June 26, 2013
Bookmark and Share
Acquisition enhances Veeva Network – a complete, cloud-based customer master solution.

Following Veeva Systems’ recent unveiling of Veeva Network, the life sciences industry’s first cloud-based customer master solution, the company has acquired national healthcare data provider, AdvantageMS. The acquisition adds a database of more than seven million active healthcare providers (HCPs), healthcare organizations (HCOs) and affiliations across the United States to Veeva Network. This acquired data, combined with Veeva’s advanced cloud software and data stewardship services, provides life sciences companies with an accurate, up-to-date view of their customers in one solution.

Historically, life sciences organizations have struggled to stitch together sets of non-standardized data from a myriad of sources. Generating a single source of the truth about customers that’s accurate, kept up-to-date and accessible to users has proven to be expensive, time consuming and yet still elusive for most. With Veeva’s acquisition of AdvantageMS, Veeva Network will provide pharmaceutical companies with accurate information on their customers without the complicated patchwork of systems, data and staff. Additionally, Veeva Network is integrated with Veeva CRM, so data is fully accessible to sales and marketing users for improved efficiency.

“AdvantageMS is an organization of great people and their data is one of the most reliable sources of U.S. healthcare data, trusted by life sciences organizations of all sizes for over a decade,” said Peter Gassner, president and CEO of Veeva Systems. “We are thrilled to have AdvantageMS join the Veeva team.”

AdvantageMS also provides Veeva Network with data compliance services and one of the most detailed HCP email lists available, with over 500,000 verified records. The database is 100% permission-based and contains workplace email addresses, including hard-to-find group practice and hospital-based emails. As a result, life sciences companies will be able to reliably extend their digital outreach programs.

“Like AdvantageMS, Veeva is dedicated to customer success. By combining our data and services with the Veeva Network application we will deliver exceptional value to our joint customers,” explained Richard Johnston, CEO of AdvantageMS.

AdvantageMS customers will continue to receive existing data services, while joint Veeva and AdvantageMS customers will be able to benefit from the strategic acquisition through Veeva Network – planned for general availability throughout the United States and China in late 2013, with other markets to follow.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Veeva Systems Acquires Zinc Ahead
Combination set to transform productivity and compliance across the digital supply chain.
Saturday, October 03, 2015
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
A Boost for Regenerative Medicine
Growing tissues and organs in the lab for transplantation into patients could become easier after scientists discovered an effective way to produce three-dimensional networks of blood vessels, vital for tissue survival yet a current stumbling block in regenerative medicine.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
Nanoparticles Target, Transform Fat Tissue
Nanoparticles designed to target white fat and convert it to calorie-burning brown fat slowed weight gain in obese mice without affecting food intake. This proof-of-concept work could lead to new therapies to treat obesity.
New Cancer Fighters Emerge From Lab
Rice University lab simplifies total synthesis of anti-cancer agent.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!